Results 51 to 60 of about 27,421 (247)

Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes [PDF]

, 2023
Background: Novel biomarkers of vascular disease in diabetes could help identify new mechanistic pathways. Osteocalcin, osteoprotegerin, and osteopontin are key molecules involved in bone and vascular calcification processes, both of which are ...
Rury R. Holman, Lucia Coraggio, Morviducci, Lelio, Buzzetti, Raffaella, Ernesto Maddaloni, Pugliese, Giuseppe, Marco G. Baroni, Coraggio, Lucia, Napoli, Nicola, Maddaloni, Ernesto, Morano, Susanna, Giuseppe Pugliese, De Cosmo, Salvatore, Leonetti, Frida, Copetti, Massimiliano, Sentinelli, Federica, Cossu, Efisio, Rocco Amendolara, Nicola Napoli, D'Onofrio, Luca, Trischitta, Vincenzo, Massimiliano Copetti, Sabrina Prudente, Raffaella Buzzetti, D'Angelo, Paola, Luca D’Onofrio, Park, Kyoungmin, Susanna Morano, Baroni, Marco G, Paola D’Angelo, the SUMMER Study in Diabetes Group, Vincenzo Trischitta, Holman, Rury R, Frida Leonetti, Lelio Morviducci, Amendolara, Rocco, Efisio Cossu, Cosmo, Salvatore De, Maria G. Cavallo, Salvatore De Cosmo, Prudente, Sabrina, Kyoungmin Park, Cavallo, Maria G   +42 more
core   +1 more source

CD248/Endosialin regulates synovial fibroblast state to control coupling of inflammation and bone damage in murine models of immune‐mediated inflammatory arthritis and ageing

Arthritis &Rheumatology, Accepted Article.
Objective Synovial fibroblasts directly contribute to inflammation and damage in immune‐mediated inflammatory arthritis. CD248/Endosialin is expressed by fibroblasts in the synovium, is highly upregulated during inflammation and has been proposed as a potential therapeutic target.
Samuel Kemble, Corinna Wehmeyer, James M. Brown, Charlotte G. Smith, Holly R. Adams, Eva Crombie, Ellie Northall, Maryam Imran, Paulynn Chin, Harris R. Perlman, Christopher D. Buckley, Adam P. Croft, Amy J. Naylor   +12 more
wiley   +1 more source

Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality

, 2021
Joanna Kamińska,1,* Marek Stopiński,1,* Krzysztof Mucha,2,3 Michał Pac,2 Marek Gołębiowski,4 Monika A Niewczas,5,6 Leszek Pączek,2,3 Bartosz Foroncewicz2 1Department of Internal Diseases and Dialysis Unit, West Hospital of Saint John Paul II, Grodzisk ...
Pączek L, Niewczas MA, Stopiński M, Mucha K, Foroncewicz B, Kamińska J, Pac M, Gołębiowski M   +7 more
core  

Circulating levels of osteoprotegerin and sRANKL and the effect of methotrexate in patients with rheumatoid arthritis

Indian Journal of Rheumatology, 2018
Background: Receptor activator of nuclear factor κβ ligand (RANKL) and osteoprotegerin (OPG) are pivotal molecules involved in osteoclast activation and resorption.
Aadhaar Dhooria, Narendhiran Pandurangan, Karthik Vinay Mahesh, Suchet Sachdev, Aman Sharma, Shefali Sharma, Nidhi Gupta, Varun Dhir   +7 more
doaj   +1 more source

Pangasius djambal gelatin increases osteoprotegerin, decreases RANK and RANKL after tooth extraction in vivo

Dental Journal, 2023
Background: Osteoprotegerin (OPG) plays a role in preventing osteoclast formation and osteoclastic bone resorption by inhibiting the receptor activator nuclear factor-β and its ligand (RANK–RANKL) interaction that causes bone resorption.
Fredy Mardiyantoro, Nenny Prasetyaningrum, Lukman H. Hidayat, Uswatun Khasanah, Virginia C. Roring, Ahida Muizun, Varellia A. W. Kardikadewi   +6 more
doaj   +1 more source

Neurovascular coupling in bone regeneration: Mechanisms, advanced biomaterials and challenges

BMEMat, EarlyView.
This figure illustrates various material strategies for neurovascularized bone regeneration, including electroactive scaffolds, ion‐loaded materials, drug delivery systems, surface modifications, cells/cell products, growth factors, and peptides. These approaches aim to synergistically promote the regeneration of neural, vascular, and bone tissues ...
Yixin Ma, Nan Jiang, Liyuan Chen, He Zhang, Xinjia Cai, Karan Gulati, Danqing He, Zhigang Cai, Yan Liu   +8 more
wiley   +1 more source

Effect of anatomical location (mandible vs maxilla) of dental implants on the BMP-2, BMP-7, sRANKL and OPG levels in periimplant crevicular fluid during osseointegration. A pilot study

Selcuk Dental Journal, 2019
Background:The aim of this study was to investigate levels of bone morphogenetic protein-2 (BMP-2), BMP-7, soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) in the peri-implant crevicular fluid (PICF) of  implants ...
Mehmet Sağlam, Doğan Dolanmaz, Emrah Koçak, Burcu Poyraz, Özgür İnan, Niyazi Dündar, Sema Hakkı   +6 more
doaj   +1 more source

Pathogenetic and diagnostic role of osteoprotegerin in the combined course of osteoarthritis and obesity

Journal of Education, Health and Sport, 2022
In recent years, it has been proven that the formation of OA can occur against the background of impaired bone metabolism. Bone remodeling is considered as a continuous complex process aimed at eliminating microdamages and updating the bone matrix. A
A. Litvynova, L. Pasiieshvili
doaj   +1 more source

Serum osteoprotegerin and renal osteodystrophy [PDF]

Nephrology Dialysis Transplantation, 2002
Numerous growth factors and cytokines are known to modulate bone turnover. An important, recently discovered complex involved in osteoclastogenesis is the osteoprotegerin/osteoprotegerin-ligand (OPG/OPGL) cytokine complex, which is produced by osteoblasts.
Coen, Giorgio, Ballanti, Paola, Balducci, Alessandro, Calabria, Santo, Fischer, Maria Stephanie, Jankovic, Ljiljana, Manni, Micaela, Morosetti, Massimo, Moscaritolo, Eleonora, Sardella, Daniela, Bonucci, Ermanno   +10 more
openaire   +3 more sources

Pregnancy‐ and lactation‐associated osteoporosis: A position statement of the IAPM, IOF, ECTS, ESCEO, IMS, and EMAS

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Pregnancy‐ and lactation‐associated osteoporosis (PLO) is a syndrome characterized by fragility fractures (most commonly vertebral, often multiple) occurring in late pregnancy or the early postpartum period. This position statement summarizes the current knowledge of PLO, and the recommended procedure for assessment, diagnosis and treatment ...
Peyman Hadji, Apostolos Athanasiadis, Maria‐Luisa Brandi, Marlene Chakhtoura, Manju Chandran, Frank Chervenak, Amos Grünebaum, Irene Lambrinoudaki, Willem F. Lems, Apostolos M. Mamopoulos, Eugene McCloskey, Rossella E. Nappi, Jessica Pepe, Jean‐Yves Reginster, René Rizzoli, Petra Stute, Şansın Tuzun, Amanda J. Vincent, Maria Belen Zanchetta, M. Carola Zillikens, Ioannis Kyvernitakis   +20 more
wiley   +1 more source